Companies: 10,795·Total market cap: $144.5T
Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

MNPRNASDAQHealthcare● Active
$60.78
+$1.30(+2.19%)
Market Cap$407168867
P/E Ratio—
52W High$105
52W Low$29.18
SEC Filings

Monopar Therapeutics Inc. (MNPR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001645469 · MNPR · NASDAQ · as of Jun 8, 2026

Filing snapshot

497
Total Filings
8-K
Latest Form
2026-05-29
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001645469 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-01
Fiscal Year End
Apr 1, 2026
Accession No.
0001437749-26-010841
Primary Document
mnpr20251231c_10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001645469 · Accession 0001437749-26-010841

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-05-29Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-05-29
View
8-KCurrent Report
FORM 8-K
2026-05-19
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
10-QQuarterly Report
FORM 10-Q
2026-05-14
View
8-KCurrent Report
FORM 8-K
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
ARSARS
FORM ARS
2026-04-30
View
DEFA14AProxy Statement (Additional)
FORM DEFA14A
2026-04-30
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-30
View
8-KCurrent Report
FORM 8-K
2026-04-20
View
10-K/AAnnual Report (Amended)
FORM 10-K/A
2026-04-01
View
8-KCurrent Report
FORM 8-K
2026-03-27
View
10-KAnnual Report
FORM 10-K
2026-03-27
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-04
View
8-KCurrent Report
FORM 8-K
2026-03-02
View
Showing 1–15 of 282 filingsForm 4 / 144 hidden· 497 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001645469  |  Exchange: NASDAQ · Healthcare

Monopar Therapeutics Inc. (NASDAQ: MNPR) has submitted 497 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001645469, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Monopar Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Monopar Therapeutics Inc. 10-K was filed on 2026-04-01 for fiscal year ending 2026. Historical MNPR 10-K annual reports are available from 2015 through 2026.

Investors researching Monopar Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KALV SEC Filings →LXRX SEC Filings →OMER SEC Filings →FDMT SEC Filings →NMRA SEC Filings →BCYC SEC Filings →CMPX SEC Filings →AKBA SEC Filings →
→ MNPR Financials→ MNPR Earnings→ MNPR Insider Trades

Frequently Asked Questions

MNPR SEC Filings · 8 questions

Monopar Therapeutics Inc. (MNPR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 497 filings and access original documents at no cost. Monopar Therapeutics Inc.'s CIK is 0001645469.

MNPR SEC filingsMonopar Therapeutics Inc. SEC documentsfind MNPR 10-K